HEADER DNA BINDING PROTEIN 12-FEB-16 5I4V TITLE DISCOVERY OF NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR (LXR) BETA TITLE 2 AGONISTS COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYSTEROLS RECEPTOR LXR-BETA,NUCLEAR RECEPTOR COACTIVATOR COMPND 3 2; COMPND 4 CHAIN: A, E; COMPND 5 SYNONYM: LIVER X RECEPTOR BETA,NUCLEAR RECEPTOR NER,NUCLEAR RECEPTOR COMPND 6 SUBFAMILY 1 GROUP H MEMBER 2,UBIQUITOUSLY-EXPRESSED NUCLEAR RECEPTOR, COMPND 7 NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75,BHLHE75, COMPND 8 TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: RETINOIC ACID RECEPTOR RXR-BETA,NUCLEAR RECEPTOR COMPND 13 COACTIVATOR 2; COMPND 14 CHAIN: B, F; COMPND 15 SYNONYM: NUCLEAR RECEPTOR SUBFAMILY 2 GROUP B MEMBER 2,RETINOID X COMPND 16 RECEPTOR BETA,NCOA-2,CLASS E BASIC HELIX-LOOP-HELIX PROTEIN 75, COMPND 17 BHLHE75,TRANSCRIPTIONAL INTERMEDIARY FACTOR 2,HTIF2; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NR1H2, LXRB, NER, UNR, NCOA2, BHLHE75, SRC2, TIF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A(+); SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: RXRB, NR2B2, NCOA2, BHLHE75, SRC2, TIF2; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PET21A(+) KEYWDS LXRBETA-LBD, RXRBETA-LBD, HETERODIMER, AGONIST, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR G.CHEN,B.M.MCKEEVER REVDAT 2 27-SEP-23 5I4V 1 JRNL REMARK REVDAT 1 29-JUN-16 5I4V 0 JRNL AUTH Y.ZHENG,L.ZHUANG,K.Y.FAN,C.M.TICE,W.ZHAO,C.DONG,S.D.LOTESTA, JRNL AUTH 2 K.LEFTHERIS,P.R.LINDBLOM,Z.LIU,J.SHIMADA,P.B.NOTO,S.MENG, JRNL AUTH 3 A.HARDY,L.HOWARD,P.KROSKY,J.GUO,K.LIPINSKI,G.KANDPAL, JRNL AUTH 4 Y.BUKHTIYAROV,Y.ZHAO,D.LALA,R.VAN ORDEN,J.ZHOU,G.CHEN,Z.WU, JRNL AUTH 5 B.M.MCKEEVER,G.M.MCGEEHAN,R.E.GREGG,D.A.CLAREMON,S.B.SINGH JRNL TITL DISCOVERY OF A NOVEL, ORALLY EFFICACIOUS LIVER X RECEPTOR JRNL TITL 2 (LXR) BETA AGONIST. JRNL REF J.MED.CHEM. V. 59 3264 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 26990539 JRNL DOI 10.1021/ACS.JMEDCHEM.5B02029 REMARK 2 REMARK 2 RESOLUTION. 2.61 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0071 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.61 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 28161 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.211 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1479 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.61 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.68 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1533 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.70 REMARK 3 BIN R VALUE (WORKING SET) : 0.3250 REMARK 3 BIN FREE R VALUE SET COUNT : 76 REMARK 3 BIN FREE R VALUE : 0.3340 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7536 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 41 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 59.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.11 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.07000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : -0.09000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.349 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.315 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 33.343 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7743 ; 0.007 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7678 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10459 ; 1.133 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17616 ; 0.895 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 926 ; 4.565 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 359 ;38.833 ;23.565 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1419 ;16.768 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 66 ;21.620 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1195 ; 0.057 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8533 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1775 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3740 ; 1.943 ; 4.515 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3739 ; 1.944 ; 4.514 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4654 ; 3.187 ; 6.755 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4655 ; 3.186 ; 6.757 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4003 ; 2.488 ; 4.890 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 4003 ; 2.488 ; 4.890 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 5806 ; 4.255 ; 7.203 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 8785 ; 6.061 ;35.531 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 8786 ; 6.061 ;35.536 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 2 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 218 477 E 218 477 15153 0.11 0.05 REMARK 3 2 B 297 543 F 297 543 12970 0.12 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 218 A 477 REMARK 3 ORIGIN FOR THE GROUP (A): -6.1449 -1.1094 -22.3685 REMARK 3 T TENSOR REMARK 3 T11: 0.0556 T22: 0.1121 REMARK 3 T33: 0.0173 T12: -0.0075 REMARK 3 T13: -0.0080 T23: -0.0130 REMARK 3 L TENSOR REMARK 3 L11: 0.2952 L22: 1.3596 REMARK 3 L33: 0.3519 L12: 0.1099 REMARK 3 L13: 0.1182 L23: -0.0027 REMARK 3 S TENSOR REMARK 3 S11: -0.0264 S12: 0.0088 S13: 0.0393 REMARK 3 S21: -0.0639 S22: 0.0545 S23: 0.0764 REMARK 3 S31: 0.0097 S32: -0.0198 S33: -0.0282 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 297 B 543 REMARK 3 ORIGIN FOR THE GROUP (A): 12.8041 -15.1235 -5.8629 REMARK 3 T TENSOR REMARK 3 T11: 0.0196 T22: 0.1253 REMARK 3 T33: 0.0121 T12: 0.0409 REMARK 3 T13: -0.0057 T23: -0.0117 REMARK 3 L TENSOR REMARK 3 L11: 0.5649 L22: 1.1769 REMARK 3 L33: 2.0375 L12: -0.1166 REMARK 3 L13: -0.2414 L23: 0.2678 REMARK 3 S TENSOR REMARK 3 S11: -0.0468 S12: -0.0961 S13: 0.0097 REMARK 3 S21: 0.0728 S22: 0.0048 S23: -0.0827 REMARK 3 S31: 0.1530 S32: 0.2681 S33: 0.0419 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 218 E 477 REMARK 3 ORIGIN FOR THE GROUP (A): -15.1641 9.9716 12.9218 REMARK 3 T TENSOR REMARK 3 T11: 0.0639 T22: 0.0755 REMARK 3 T33: 0.0101 T12: -0.0378 REMARK 3 T13: -0.0196 T23: 0.0098 REMARK 3 L TENSOR REMARK 3 L11: 1.2021 L22: 0.3378 REMARK 3 L33: 0.9283 L12: -0.2459 REMARK 3 L13: -0.0619 L23: 0.2167 REMARK 3 S TENSOR REMARK 3 S11: 0.0788 S12: -0.0707 S13: -0.0873 REMARK 3 S21: -0.0034 S22: -0.0391 S23: 0.0127 REMARK 3 S31: 0.1224 S32: -0.0688 S33: -0.0396 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : F 297 F 544 REMARK 3 ORIGIN FOR THE GROUP (A): -2.5214 28.9927 30.1960 REMARK 3 T TENSOR REMARK 3 T11: 0.0107 T22: 0.0991 REMARK 3 T33: 0.0274 T12: -0.0107 REMARK 3 T13: 0.0047 T23: -0.0374 REMARK 3 L TENSOR REMARK 3 L11: 0.7522 L22: 1.4059 REMARK 3 L33: 1.0000 L12: 0.0907 REMARK 3 L13: -0.3157 L23: 0.2000 REMARK 3 S TENSOR REMARK 3 S11: 0.0258 S12: -0.1116 S13: 0.1034 REMARK 3 S21: 0.0569 S22: 0.1079 S23: -0.0189 REMARK 3 S31: 0.0012 S32: 0.0970 S33: -0.1337 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5I4V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000211562. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29640 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.609 REMARK 200 RESOLUTION RANGE LOW (A) : 82.670 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 200 DATA REDUNDANCY : 12.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.61 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.68 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1UHL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1UL OF SCLXRBETA-LBD/SCRXRBETA-LBD @ REMARK 280 10 MG PROTEIN/ML IN 20 MM TRIS-HCL PH 8.0, 150 MM NACL, 5 MM DTT REMARK 280 CONTAINING 1MM LIGAND AND LESS THAN 2%(V/V) DMSO WAS MIXED WITH REMARK 280 1UL OF RESERVOIR SOLUTION (0.2M LICL, 16-20%(W/V) PEG3350, 7-10% REMARK 280 (V/V) ETHYLENE GLYCOL, 0.01M STRONTIUM CHLORIDE) ON A CIRCULAR, REMARK 280 SILANIZED GLASS COVER SLIDE AND INVERTED AND SEALED WITH SILICON REMARK 280 GREASE OVER A WELL OF 200UL OF RESERVOIR SOLUTION. REMARK 280 CRYSTALLIZATION PLATES WERE INCUBATED AT 23 DEG C FOR 2-5 DAYS REMARK 280 BEFORE RODS WOULD APPEAR MEASURING 50 TO 100UM LONG., VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.31850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 71.63700 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.61050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 71.63700 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.31850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.61050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1800 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21480 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 211 REMARK 465 SER A 212 REMARK 465 HIS A 213 REMARK 465 MET A 214 REMARK 465 GLY A 215 REMARK 465 GLU A 216 REMARK 465 GLY A 217 REMARK 465 SER A 478 REMARK 465 SER A 479 REMARK 465 SER A 480 REMARK 465 MET B 293 REMARK 465 GLY B 294 REMARK 465 ALA B 295 REMARK 465 PRO B 296 REMARK 465 GLN B 313 REMARK 465 LYS B 314 REMARK 465 SER B 315 REMARK 465 ASP B 316 REMARK 465 GLN B 317 REMARK 465 GLY B 318 REMARK 465 VAL B 319 REMARK 465 GLU B 320 REMARK 465 GLY B 321 REMARK 465 PRO B 322 REMARK 465 GLY B 323 REMARK 465 GLY B 324 REMARK 465 THR B 325 REMARK 465 GLY B 326 REMARK 465 GLY B 327 REMARK 465 SER B 328 REMARK 465 GLY B 329 REMARK 465 SER B 330 REMARK 465 SER B 331 REMARK 465 PRO B 332 REMARK 465 ASN B 333 REMARK 465 ASP B 334 REMARK 465 GLY B 514 REMARK 465 ASP B 515 REMARK 465 THR B 516 REMARK 465 GLY B 529 REMARK 465 SER B 530 REMARK 465 GLY B 531 REMARK 465 SER B 532 REMARK 465 GLY B 533 REMARK 465 SER B 534 REMARK 465 HIS B 535 REMARK 465 ASP B 544 REMARK 465 SER B 545 REMARK 465 SER B 546 REMARK 465 SER B 547 REMARK 465 GLY E 211 REMARK 465 SER E 212 REMARK 465 HIS E 213 REMARK 465 MET E 214 REMARK 465 GLY E 215 REMARK 465 GLU E 216 REMARK 465 GLY E 217 REMARK 465 GLY E 255 REMARK 465 ALA E 256 REMARK 465 ASP E 257 REMARK 465 PRO E 258 REMARK 465 ALA E 259 REMARK 465 SER E 260 REMARK 465 HIS E 460 REMARK 465 GLU E 461 REMARK 465 GLY E 462 REMARK 465 SER E 463 REMARK 465 GLY E 464 REMARK 465 SER E 465 REMARK 465 GLY E 466 REMARK 465 SER E 467 REMARK 465 HIS E 468 REMARK 465 SER E 478 REMARK 465 SER E 479 REMARK 465 SER E 480 REMARK 465 MET F 293 REMARK 465 GLY F 294 REMARK 465 ALA F 295 REMARK 465 PRO F 296 REMARK 465 GLN F 313 REMARK 465 LYS F 314 REMARK 465 SER F 315 REMARK 465 ASP F 316 REMARK 465 GLN F 317 REMARK 465 GLY F 318 REMARK 465 VAL F 319 REMARK 465 GLU F 320 REMARK 465 GLY F 321 REMARK 465 PRO F 322 REMARK 465 GLY F 323 REMARK 465 GLY F 324 REMARK 465 THR F 325 REMARK 465 GLY F 326 REMARK 465 GLY F 327 REMARK 465 SER F 328 REMARK 465 GLY F 329 REMARK 465 SER F 330 REMARK 465 SER F 331 REMARK 465 PRO F 332 REMARK 465 ASN F 333 REMARK 465 ASP F 334 REMARK 465 ASP F 515 REMARK 465 THR F 516 REMARK 465 PRO F 517 REMARK 465 ILE F 518 REMARK 465 GLY F 529 REMARK 465 SER F 530 REMARK 465 GLY F 531 REMARK 465 SER F 532 REMARK 465 SER F 545 REMARK 465 SER F 546 REMARK 465 SER F 547 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP F 519 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE B 447 NH1 ARG B 464 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 330 -138.39 51.16 REMARK 500 ASP A 332 41.02 -147.07 REMARK 500 VAL B 311 41.02 -100.43 REMARK 500 HIS B 359 -3.61 73.31 REMARK 500 LEU B 542 56.67 -118.96 REMARK 500 LEU E 330 -138.34 51.26 REMARK 500 ASP E 332 41.42 -148.62 REMARK 500 ASP E 458 68.86 60.71 REMARK 500 VAL F 311 40.35 -102.34 REMARK 500 HIS F 359 -3.86 73.03 REMARK 500 THR F 399 -9.07 -53.12 REMARK 500 GLN F 543 -65.15 -137.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 67S A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 67S E 501 DBREF 5I4V A 211 461 UNP P55055 NR1H2_HUMAN 210 460 DBREF 5I4V A 468 480 UNP Q15596 NCOA2_HUMAN 687 699 DBREF 5I4V B 293 528 UNP P28702 RXRB_HUMAN 293 528 DBREF 5I4V B 535 547 UNP Q15596 NCOA2_HUMAN 687 699 DBREF 5I4V E 211 461 UNP P55055 NR1H2_HUMAN 210 460 DBREF 5I4V E 468 480 UNP Q15596 NCOA2_HUMAN 687 699 DBREF 5I4V F 293 528 UNP P28702 RXRB_HUMAN 293 528 DBREF 5I4V F 535 547 UNP Q15596 NCOA2_HUMAN 687 699 SEQADV 5I4V HIS A 213 UNP P55055 GLY 212 ENGINEERED MUTATION SEQADV 5I4V MET A 214 UNP P55055 GLU 213 ENGINEERED MUTATION SEQADV 5I4V ALA A 259 UNP P55055 GLN 258 ENGINEERED MUTATION SEQADV 5I4V GLY A 261 UNP P55055 ARG 260 ENGINEERED MUTATION SEQADV 5I4V SER A 262 UNP P55055 ASP 261 ENGINEERED MUTATION SEQADV 5I4V SER A 264 UNP P55055 ARG 263 ENGINEERED MUTATION SEQADV 5I4V GLY A 462 UNP P55055 LINKER SEQADV 5I4V SER A 463 UNP P55055 LINKER SEQADV 5I4V GLY A 464 UNP P55055 LINKER SEQADV 5I4V SER A 465 UNP P55055 LINKER SEQADV 5I4V GLY A 466 UNP P55055 LINKER SEQADV 5I4V SER A 467 UNP P55055 LINKER SEQADV 5I4V MET B 293 UNP P28702 GLY 293 ENGINEERED MUTATION SEQADV 5I4V GLY B 529 UNP P28702 LINKER SEQADV 5I4V SER B 530 UNP P28702 LINKER SEQADV 5I4V GLY B 531 UNP P28702 LINKER SEQADV 5I4V SER B 532 UNP P28702 LINKER SEQADV 5I4V GLY B 533 UNP P28702 LINKER SEQADV 5I4V SER B 534 UNP P28702 LINKER SEQADV 5I4V HIS E 213 UNP P55055 GLY 212 ENGINEERED MUTATION SEQADV 5I4V MET E 214 UNP P55055 GLU 213 ENGINEERED MUTATION SEQADV 5I4V ALA E 259 UNP P55055 GLN 258 ENGINEERED MUTATION SEQADV 5I4V GLY E 261 UNP P55055 ARG 260 ENGINEERED MUTATION SEQADV 5I4V SER E 262 UNP P55055 ASP 261 ENGINEERED MUTATION SEQADV 5I4V SER E 264 UNP P55055 ARG 263 ENGINEERED MUTATION SEQADV 5I4V GLY E 462 UNP P55055 LINKER SEQADV 5I4V SER E 463 UNP P55055 LINKER SEQADV 5I4V GLY E 464 UNP P55055 LINKER SEQADV 5I4V SER E 465 UNP P55055 LINKER SEQADV 5I4V GLY E 466 UNP P55055 LINKER SEQADV 5I4V SER E 467 UNP P55055 LINKER SEQADV 5I4V MET F 293 UNP P28702 GLY 293 ENGINEERED MUTATION SEQADV 5I4V GLY F 529 UNP P28702 LINKER SEQADV 5I4V SER F 530 UNP P28702 LINKER SEQADV 5I4V GLY F 531 UNP P28702 LINKER SEQADV 5I4V SER F 532 UNP P28702 LINKER SEQADV 5I4V GLY F 533 UNP P28702 LINKER SEQADV 5I4V SER F 534 UNP P28702 LINKER SEQRES 1 A 270 GLY SER HIS MET GLY GLU GLY VAL GLN LEU THR ALA ALA SEQRES 2 A 270 GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA GLN LEU SEQRES 3 A 270 GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO LYS VAL SEQRES 4 A 270 THR PRO TRP PRO LEU GLY ALA ASP PRO ALA SER GLY SER SEQRES 5 A 270 ALA SER GLN GLN ARG PHE ALA HIS PHE THR GLU LEU ALA SEQRES 6 A 270 ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA LYS GLN SEQRES 7 A 270 VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP GLN ILE SEQRES 8 A 270 ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET LEU LEU SEQRES 9 A 270 GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU CYS ILE SEQRES 10 A 270 THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP ASP PHE SEQRES 11 A 270 HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN PRO ILE SEQRES 12 A 270 PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY LEU ASP SEQRES 13 A 270 ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN ILE PHE SEQRES 14 A 270 SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY ARG VAL SEQRES 15 A 270 GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU LEU SER SEQRES 16 A 270 TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU ARG PHE SEQRES 17 A 270 PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG THR LEU SEQRES 18 A 270 SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU ARG LEU SEQRES 19 A 270 GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU ILE TRP SEQRES 20 A 270 ASP VAL HIS GLU GLY SER GLY SER GLY SER HIS LYS ILE SEQRES 21 A 270 LEU HIS ARG LEU LEU GLN ASP SER SER SER SEQRES 1 B 255 MET GLY ALA PRO GLU GLU MET PRO VAL ASP ARG ILE LEU SEQRES 2 B 255 GLU ALA GLU LEU ALA VAL GLU GLN LYS SER ASP GLN GLY SEQRES 3 B 255 VAL GLU GLY PRO GLY GLY THR GLY GLY SER GLY SER SER SEQRES 4 B 255 PRO ASN ASP PRO VAL THR ASN ILE CYS GLN ALA ALA ASP SEQRES 5 B 255 LYS GLN LEU PHE THR LEU VAL GLU TRP ALA LYS ARG ILE SEQRES 6 B 255 PRO HIS PHE SER SER LEU PRO LEU ASP ASP GLN VAL ILE SEQRES 7 B 255 LEU LEU ARG ALA GLY TRP ASN GLU LEU LEU ILE ALA SER SEQRES 8 B 255 PHE SER HIS ARG SER ILE ASP VAL ARG ASP GLY ILE LEU SEQRES 9 B 255 LEU ALA THR GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SEQRES 10 B 255 SER ALA GLY VAL GLY ALA ILE PHE ASP ARG VAL LEU THR SEQRES 11 B 255 GLU LEU VAL SER LYS MET ARG ASP MET ARG MET ASP LYS SEQRES 12 B 255 THR GLU LEU GLY CYS LEU ARG ALA ILE ILE LEU PHE ASN SEQRES 13 B 255 PRO ASP ALA LYS GLY LEU SER ASN PRO SER GLU VAL GLU SEQRES 14 B 255 VAL LEU ARG GLU LYS VAL TYR ALA SER LEU GLU THR TYR SEQRES 15 B 255 CYS LYS GLN LYS TYR PRO GLU GLN GLN GLY ARG PHE ALA SEQRES 16 B 255 LYS LEU LEU LEU ARG LEU PRO ALA LEU ARG SER ILE GLY SEQRES 17 B 255 LEU LYS CYS LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE SEQRES 18 B 255 GLY ASP THR PRO ILE ASP THR PHE LEU MET GLU MET LEU SEQRES 19 B 255 GLU ALA GLY SER GLY SER GLY SER HIS LYS ILE LEU HIS SEQRES 20 B 255 ARG LEU LEU GLN ASP SER SER SER SEQRES 1 E 270 GLY SER HIS MET GLY GLU GLY VAL GLN LEU THR ALA ALA SEQRES 2 E 270 GLN GLU LEU MET ILE GLN GLN LEU VAL ALA ALA GLN LEU SEQRES 3 E 270 GLN CYS ASN LYS ARG SER PHE SER ASP GLN PRO LYS VAL SEQRES 4 E 270 THR PRO TRP PRO LEU GLY ALA ASP PRO ALA SER GLY SER SEQRES 5 E 270 ALA SER GLN GLN ARG PHE ALA HIS PHE THR GLU LEU ALA SEQRES 6 E 270 ILE ILE SER VAL GLN GLU ILE VAL ASP PHE ALA LYS GLN SEQRES 7 E 270 VAL PRO GLY PHE LEU GLN LEU GLY ARG GLU ASP GLN ILE SEQRES 8 E 270 ALA LEU LEU LYS ALA SER THR ILE GLU ILE MET LEU LEU SEQRES 9 E 270 GLU THR ALA ARG ARG TYR ASN HIS GLU THR GLU CYS ILE SEQRES 10 E 270 THR PHE LEU LYS ASP PHE THR TYR SER LYS ASP ASP PHE SEQRES 11 E 270 HIS ARG ALA GLY LEU GLN VAL GLU PHE ILE ASN PRO ILE SEQRES 12 E 270 PHE GLU PHE SER ARG ALA MET ARG ARG LEU GLY LEU ASP SEQRES 13 E 270 ASP ALA GLU TYR ALA LEU LEU ILE ALA ILE ASN ILE PHE SEQRES 14 E 270 SER ALA ASP ARG PRO ASN VAL GLN GLU PRO GLY ARG VAL SEQRES 15 E 270 GLU ALA LEU GLN GLN PRO TYR VAL GLU ALA LEU LEU SER SEQRES 16 E 270 TYR THR ARG ILE LYS ARG PRO GLN ASP GLN LEU ARG PHE SEQRES 17 E 270 PRO ARG MET LEU MET LYS LEU VAL SER LEU ARG THR LEU SEQRES 18 E 270 SER SER VAL HIS SER GLU GLN VAL PHE ALA LEU ARG LEU SEQRES 19 E 270 GLN ASP LYS LYS LEU PRO PRO LEU LEU SER GLU ILE TRP SEQRES 20 E 270 ASP VAL HIS GLU GLY SER GLY SER GLY SER HIS LYS ILE SEQRES 21 E 270 LEU HIS ARG LEU LEU GLN ASP SER SER SER SEQRES 1 F 255 MET GLY ALA PRO GLU GLU MET PRO VAL ASP ARG ILE LEU SEQRES 2 F 255 GLU ALA GLU LEU ALA VAL GLU GLN LYS SER ASP GLN GLY SEQRES 3 F 255 VAL GLU GLY PRO GLY GLY THR GLY GLY SER GLY SER SER SEQRES 4 F 255 PRO ASN ASP PRO VAL THR ASN ILE CYS GLN ALA ALA ASP SEQRES 5 F 255 LYS GLN LEU PHE THR LEU VAL GLU TRP ALA LYS ARG ILE SEQRES 6 F 255 PRO HIS PHE SER SER LEU PRO LEU ASP ASP GLN VAL ILE SEQRES 7 F 255 LEU LEU ARG ALA GLY TRP ASN GLU LEU LEU ILE ALA SER SEQRES 8 F 255 PHE SER HIS ARG SER ILE ASP VAL ARG ASP GLY ILE LEU SEQRES 9 F 255 LEU ALA THR GLY LEU HIS VAL HIS ARG ASN SER ALA HIS SEQRES 10 F 255 SER ALA GLY VAL GLY ALA ILE PHE ASP ARG VAL LEU THR SEQRES 11 F 255 GLU LEU VAL SER LYS MET ARG ASP MET ARG MET ASP LYS SEQRES 12 F 255 THR GLU LEU GLY CYS LEU ARG ALA ILE ILE LEU PHE ASN SEQRES 13 F 255 PRO ASP ALA LYS GLY LEU SER ASN PRO SER GLU VAL GLU SEQRES 14 F 255 VAL LEU ARG GLU LYS VAL TYR ALA SER LEU GLU THR TYR SEQRES 15 F 255 CYS LYS GLN LYS TYR PRO GLU GLN GLN GLY ARG PHE ALA SEQRES 16 F 255 LYS LEU LEU LEU ARG LEU PRO ALA LEU ARG SER ILE GLY SEQRES 17 F 255 LEU LYS CYS LEU GLU HIS LEU PHE PHE PHE LYS LEU ILE SEQRES 18 F 255 GLY ASP THR PRO ILE ASP THR PHE LEU MET GLU MET LEU SEQRES 19 F 255 GLU ALA GLY SER GLY SER GLY SER HIS LYS ILE LEU HIS SEQRES 20 F 255 ARG LEU LEU GLN ASP SER SER SER HET 67S A 501 33 HET 67S E 501 33 HETNAM 67S {2-[(2R)-4-[4-(HYDROXYMETHYL)-3-(METHYLSULFONYL) HETNAM 2 67S PHENYL]-2-(PROPAN-2-YL)PIPERAZIN-1-YL]-4- HETNAM 3 67S (TRIFLUOROMETHYL)PYRIMIDIN-5-YL}METHANOL FORMUL 5 67S 2(C21 H27 F3 N4 O4 S) FORMUL 7 HOH *41(H2 O) HELIX 1 AA1 THR A 221 ASP A 245 1 25 HELIX 2 AA2 GLN A 246 VAL A 249 5 4 HELIX 3 AA3 GLY A 261 VAL A 289 1 29 HELIX 4 AA4 GLY A 291 LEU A 295 5 5 HELIX 5 AA5 GLY A 296 ARG A 319 1 24 HELIX 6 AA6 LYS A 337 ALA A 343 1 7 HELIX 7 AA7 GLN A 346 GLY A 364 1 19 HELIX 8 AA8 ASP A 366 PHE A 379 1 14 HELIX 9 AA9 GLU A 388 ARG A 411 1 24 HELIX 10 AB1 LEU A 416 GLN A 445 1 30 HELIX 11 AB2 PRO A 450 ASP A 458 1 9 HELIX 12 AB3 LYS A 469 ASP A 477 1 9 HELIX 13 AB4 PRO B 300 VAL B 311 1 12 HELIX 14 AB5 VAL B 336 ILE B 357 1 22 HELIX 15 AB6 PRO B 364 SER B 388 1 25 HELIX 16 AB7 ILE B 389 VAL B 391 5 3 HELIX 17 AB8 ARG B 405 ALA B 411 1 7 HELIX 18 AB9 VAL B 413 LEU B 424 1 12 HELIX 19 AC1 LEU B 424 ARG B 432 1 9 HELIX 20 AC2 ASP B 434 PHE B 447 1 14 HELIX 21 AC3 ASN B 456 TYR B 479 1 24 HELIX 22 AC4 GLY B 484 LEU B 491 1 8 HELIX 23 AC5 LEU B 491 LEU B 512 1 22 HELIX 24 AC6 ASP B 519 GLU B 527 1 9 HELIX 25 AC7 ILE B 537 LEU B 542 1 6 HELIX 26 AC8 THR E 221 ASP E 245 1 25 HELIX 27 AC9 GLN E 246 VAL E 249 5 4 HELIX 28 AD1 SER E 262 VAL E 289 1 28 HELIX 29 AD2 GLY E 291 LEU E 295 5 5 HELIX 30 AD3 GLY E 296 ARG E 319 1 24 HELIX 31 AD4 LYS E 337 ALA E 343 1 7 HELIX 32 AD5 GLN E 346 GLY E 364 1 19 HELIX 33 AD6 ASP E 366 PHE E 379 1 14 HELIX 34 AD7 GLU E 388 ARG E 411 1 24 HELIX 35 AD8 LEU E 416 GLN E 445 1 30 HELIX 36 AD9 PRO E 450 ASP E 458 1 9 HELIX 37 AE1 ILE E 470 ASP E 477 1 8 HELIX 38 AE2 PRO F 300 VAL F 311 1 12 HELIX 39 AE3 VAL F 336 ILE F 357 1 22 HELIX 40 AE4 PRO F 364 SER F 388 1 25 HELIX 41 AE5 ILE F 389 VAL F 391 5 3 HELIX 42 AE6 ARG F 405 ALA F 411 1 7 HELIX 43 AE7 VAL F 413 LEU F 424 1 12 HELIX 44 AE8 LEU F 424 MET F 431 1 8 HELIX 45 AE9 ASP F 434 PHE F 447 1 14 HELIX 46 AF1 ASN F 456 TYR F 479 1 24 HELIX 47 AF2 GLY F 484 LEU F 491 1 8 HELIX 48 AF3 LEU F 491 LEU F 512 1 22 HELIX 49 AF4 THR F 520 GLU F 527 1 8 HELIX 50 AF5 HIS F 535 LEU F 542 1 8 SHEET 1 AA1 3 TYR A 320 ASN A 321 0 SHEET 2 AA1 3 CYS A 326 PHE A 329 -1 O CYS A 326 N ASN A 321 SHEET 3 AA1 3 PHE A 333 SER A 336 -1 O PHE A 333 N PHE A 329 SHEET 1 AA2 2 GLY B 394 LEU B 396 0 SHEET 2 AA2 2 HIS B 402 HIS B 404 -1 O VAL B 403 N ILE B 395 SHEET 1 AA3 3 TYR E 320 ASN E 321 0 SHEET 2 AA3 3 CYS E 326 PHE E 329 -1 O CYS E 326 N ASN E 321 SHEET 3 AA3 3 PHE E 333 SER E 336 -1 O PHE E 333 N PHE E 329 SHEET 1 AA4 2 GLY F 394 LEU F 396 0 SHEET 2 AA4 2 HIS F 402 HIS F 404 -1 O VAL F 403 N ILE F 395 SITE 1 AC1 14 PHE A 268 PHE A 271 THR A 272 LEU A 274 SITE 2 AC1 14 SER A 278 GLU A 281 MET A 312 THR A 316 SITE 3 AC1 14 ARG A 319 PHE A 329 LEU A 330 LEU A 345 SITE 4 AC1 14 HIS A 435 HOH A 601 SITE 1 AC2 14 PHE E 268 PHE E 271 THR E 272 LEU E 274 SITE 2 AC2 14 SER E 278 GLU E 281 MET E 312 THR E 316 SITE 3 AC2 14 PHE E 329 LEU E 330 PHE E 340 LEU E 345 SITE 4 AC2 14 HIS E 435 LEU E 449 CRYST1 68.637 101.221 143.274 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014569 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009879 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006980 0.00000